Stocks in News : 26 Jul 2022
Tata Motors: The company signed a memorandum of understanding with EC Wheels India, an app based urban transportation service in Kolkata to deploy 1,000 XPRES T Electric sedans for cab transportation.
Bajaj Finserv: The company will consider proposals for bonus issue and sub-division of shares on July 28.
Larsen & Toubro: The company issued a clarification of media reports suggesting sale of block of roads and transmission project to Edelweiss fund for Rs 7,000 crore. It said that it has not signed any such agreement for sale.
Sonata Software: The company approved issue of one bonus share for every three shares.
Lupin: The company received approval from the U.S. FDA for Abbreviated New Drug Application, Azilsartan Medoxomil tablets, 40 mg and 80 mg, to market a generic equivalent of Edarbi tablets of Azurity Pharmaceuticals, Inc. The product will be manufactured at the company’s facility in Nagpur.
PSP Projects: The company received orders worth Rs 257.27 crore including two work orders from repeat clients i.e. Development of Ahmedabad Airport in Institutional segment and one Pharmaceutical Project in Industrial segments worth Rs 128.01 crores and Rs 98.99 crores respectively and remaining orders worth Rs 30.26 crores are from the Precast segment.
Tata Motors: The company signed a memorandum of understanding with EC Wheels India, an app based urban transportation service in Kolkata to deploy 1,000 XPRES T Electric sedans for cab transportation.
Bajaj Finserv: The company will consider proposals for bonus issue and sub-division of shares on July 28.
Larsen & Toubro: The company issued a clarification of media reports suggesting sale of block of roads and transmission project to Edelweiss fund for Rs 7,000 crore. It said that it has not signed any such agreement for sale.
Sonata Software: The company approved issue of one bonus share for every three shares.
Lupin: The company received approval from the U.S. FDA for Abbreviated New Drug Application, Azilsartan Medoxomil tablets, 40 mg and 80 mg, to market a generic equivalent of Edarbi tablets of Azurity Pharmaceuticals, Inc. The product will be manufactured at the company’s facility in Nagpur.
PSP Projects: The company received orders worth Rs 257.27 crore including two work orders from repeat clients i.e. Development of Ahmedabad Airport in Institutional segment and one Pharmaceutical Project in Industrial segments worth Rs 128.01 crores and Rs 98.99 crores respectively and remaining orders worth Rs 30.26 crores are from the Precast segment.
L&T Q1 : CONS. NET PROFIT UP 45 % AT 1703 CR (YOY), DOWN 53 % (QOQ)
REVENUE UP 22 % AT 35853 CR (YOY), DOWN 32 % (QOQ)
EBITDA UP 25 % AT 3957 CR (YOY), DOWN 40 % (QOQ)
MARGINS AT 11.03 % V 10.8 % (YOY), 12.3 % (QOQ)
LT rising due to good Q1 results
REVENUE UP 22 % AT 35853 CR (YOY), DOWN 32 % (QOQ)
EBITDA UP 25 % AT 3957 CR (YOY), DOWN 40 % (QOQ)
MARGINS AT 11.03 % V 10.8 % (YOY), 12.3 % (QOQ)
LT rising due to good Q1 results
L&T Review
Jefferies
Buy, TP Rs 2215
1Q rev & EBITDA 11% & 10% above expectations
Order flow growth strong at 57% YoY growth, driven by both domestic & intl segments
Management maintained its 12-15% YoY order flow & rev growth guidance
Jefferies
Buy, TP Rs 2215
1Q rev & EBITDA 11% & 10% above expectations
Order flow growth strong at 57% YoY growth, driven by both domestic & intl segments
Management maintained its 12-15% YoY order flow & rev growth guidance
*Tata Motors Ltd.* | *CMP* Rs. 458 | *M Cap* Rs. 152214 Cr | *52 W H/L* 537/268
*Result below Expectation*
Revenue from Operations came at Rs. 71934.7 Cr (-8.3% QoQ, 8.3% YoY) vs expectation of Rs. 71509.7 Cr, QoQ Rs. 78439.1 Cr, YoY Rs. 66406.5 Cr
EBIDTA came at Rs. 3180.5 Cr (-63.6% QoQ, -39.5% YoY) vs expectation of Rs. 6608.5 Cr, QoQ Rs. 8727.1 Cr, YoY Rs. 5257.6 Cr
Lower EBITDA is on account of £(236)m (Rs.2153cr) FX and commodity revaluation
EBITDA Margin came at 4.4% vs expectation of 9.2%, QoQ 11.1%, YoY 7.9%
Adj. PAT came at Rs. -6500.2 Cr vs expectation of Rs. -1039.6 Cr, QoQ Rs. -319 Cr, YoY Rs. -4453.4 Cr
Quarter EPS is Rs. -19.6
Stock is trading at P/E of 11.6x FY24E EPS
*Result below Expectation*
Revenue from Operations came at Rs. 71934.7 Cr (-8.3% QoQ, 8.3% YoY) vs expectation of Rs. 71509.7 Cr, QoQ Rs. 78439.1 Cr, YoY Rs. 66406.5 Cr
EBIDTA came at Rs. 3180.5 Cr (-63.6% QoQ, -39.5% YoY) vs expectation of Rs. 6608.5 Cr, QoQ Rs. 8727.1 Cr, YoY Rs. 5257.6 Cr
Lower EBITDA is on account of £(236)m (Rs.2153cr) FX and commodity revaluation
EBITDA Margin came at 4.4% vs expectation of 9.2%, QoQ 11.1%, YoY 7.9%
Adj. PAT came at Rs. -6500.2 Cr vs expectation of Rs. -1039.6 Cr, QoQ Rs. -319 Cr, YoY Rs. -4453.4 Cr
Quarter EPS is Rs. -19.6
Stock is trading at P/E of 11.6x FY24E EPS
Two things only stands for “B” Bitcoin & Bull 🦬 🏃♂️ 🏃♀️ 🏃♂️ 🏃♀️ 🏃♂️ 🏃♀️
MRPL Q1 : ST. NET PROFIT OF 2708 CR V 119 CR LOSS (YOY), DOWN 10 % (QOQ)
REVENUE UP 138 % AT 35915 CR (YOY), UP 27 % (QOQ)
EBITDA AT 4713 CR V 283 CR PROFIT (YOY), UP 60 % (QOQ)
MARGINS AT 13.1 % V 1.8 % (YOY), 10.4 % (QOQ)
Beneficiary of Crude prices.
WELSPUN ENT. Q1 : CONS. NET PROFIT UP 91 % AT 48 CR (YOY), DOWN 25 % (QOQ)
REVENUE UP 105 % AT 763 CR (YOY), UP 57 % (QOQ)
EBITDA UP 170 % AT 90 CR (YOY), UP 20 % (QOQ)
MARGINS AT 11.8 % V 8.97 % (YOY), 15.5 % (QOQ)
NIPPON LIFE Q1 : CONS NET PROFIT DOWN 35% AT 114CR (QOQ), 37% (YOY)
REVENUE DOWN 6% AT 316CR (QOQ) , UP 5% (YOY)
EBIT DOWN 14% AT 179CR (QOQ) UP 1% (YOY)
MARGINS 56.6% V 61.5% (QOQ) 58.6% (YOY)
Poor results
REVENUE UP 138 % AT 35915 CR (YOY), UP 27 % (QOQ)
EBITDA AT 4713 CR V 283 CR PROFIT (YOY), UP 60 % (QOQ)
MARGINS AT 13.1 % V 1.8 % (YOY), 10.4 % (QOQ)
Beneficiary of Crude prices.
WELSPUN ENT. Q1 : CONS. NET PROFIT UP 91 % AT 48 CR (YOY), DOWN 25 % (QOQ)
REVENUE UP 105 % AT 763 CR (YOY), UP 57 % (QOQ)
EBITDA UP 170 % AT 90 CR (YOY), UP 20 % (QOQ)
MARGINS AT 11.8 % V 8.97 % (YOY), 15.5 % (QOQ)
NIPPON LIFE Q1 : CONS NET PROFIT DOWN 35% AT 114CR (QOQ), 37% (YOY)
REVENUE DOWN 6% AT 316CR (QOQ) , UP 5% (YOY)
EBIT DOWN 14% AT 179CR (QOQ) UP 1% (YOY)
MARGINS 56.6% V 61.5% (QOQ) 58.6% (YOY)
Poor results
NAZARA TECH Q1 : CONS. NET PROFIT UP 117 % AT 11.5 CR (YOY), UP 422 % (QOQ)
REVENUE UP 70 % AT 223 CR (YOY), UP 27 % (QOQ(
EBITDA UP 19 % AT 30 CR (YOY) , UP 133 % (QOQ)
MARGINS AT 13.5 % V 19.2 % (YOY), 7.36 % (QOQ)
Interesting numbers
FINOTEX CHEMICAL:CONS NET PROFIT UP 109% AT 20.3CR (YOY), UP 19% (QOQ)
REVENUE UP 115% AT 135CR (YOY) ,UP 12% (QOQ)
EBITDA UP 167% AT 26.23CR (YOY),UP22%(QOQ)
MARGINS 19.32% V 17.71% (QOQ), 15.5% (YOY)
Focus on it on Monday
REVENUE UP 70 % AT 223 CR (YOY), UP 27 % (QOQ(
EBITDA UP 19 % AT 30 CR (YOY) , UP 133 % (QOQ)
MARGINS AT 13.5 % V 19.2 % (YOY), 7.36 % (QOQ)
Interesting numbers
FINOTEX CHEMICAL:CONS NET PROFIT UP 109% AT 20.3CR (YOY), UP 19% (QOQ)
REVENUE UP 115% AT 135CR (YOY) ,UP 12% (QOQ)
EBITDA UP 167% AT 26.23CR (YOY),UP22%(QOQ)
MARGINS 19.32% V 17.71% (QOQ), 15.5% (YOY)
Focus on it on Monday
EXIDE IND. Q1 : CONS. NET PROFIT UP 514 % AT 202 CR (YOY) , DOWN 95 % (QOQ)
REVENUE UP 56 % AT 4021 CR (YOY), UP 14 % (QOQ)
EBITDA UP 46 % AT 387 CR (YOY), UP 16 % (QOQ)
MARGINS AT 9.6 % V 10.3 % (YOY), 9.4 % (QOQ)
Keep an eye on performance of this stock as well
REVENUE UP 56 % AT 4021 CR (YOY), UP 14 % (QOQ)
EBITDA UP 46 % AT 387 CR (YOY), UP 16 % (QOQ)
MARGINS AT 9.6 % V 10.3 % (YOY), 9.4 % (QOQ)
Keep an eye on performance of this stock as well
Litecoin Rebounds As Buyers Target The $85 High
Key Highlights
Litecoin surges ahead The crypto trades in the bullish trend zone Litecoin (LTC) Current Statistics
The current price: $63.13
Market Capitalization: $5,294,455,615
Trading Volume: $740,028,938
Major supply zones: $200, $220, $240
Major demand zones: $100, $80, $60 Litecoin (LTC) Price Analysis July 28, 2022
Litecoin’s (LTC) price has rebounded above the moving average lines as buyers target the $85 high. The current price level is retesting the previous resistance level of June 1. On the upside, the market will rise to the high of $85 if the bulls break above the resistance at $64. However, a further upward move is doubtful as the market reaches the overbought region. The cryptocurrency will be out of a downward correction if the bulls keep the price above. 🦬👀
Key Highlights
Litecoin surges ahead The crypto trades in the bullish trend zone Litecoin (LTC) Current Statistics
The current price: $63.13
Market Capitalization: $5,294,455,615
Trading Volume: $740,028,938
Major supply zones: $200, $220, $240
Major demand zones: $100, $80, $60 Litecoin (LTC) Price Analysis July 28, 2022
Litecoin’s (LTC) price has rebounded above the moving average lines as buyers target the $85 high. The current price level is retesting the previous resistance level of June 1. On the upside, the market will rise to the high of $85 if the bulls break above the resistance at $64. However, a further upward move is doubtful as the market reaches the overbought region. The cryptocurrency will be out of a downward correction if the bulls keep the price above. 🦬👀
Market has shown all good move in last 5 DAYS and for market to stay in good mood BTC HAS TO CLOSE ABOVE $23200 in next 2 DAYS .
Monthly closing in next 36 HOURS so you can expect high volatile move in here . 🔥🔥
Monthly closing in next 36 HOURS so you can expect high volatile move in here . 🔥🔥
Stay Tuned for Tomorrow :-
IDFC FIRST BANK Q1 : ST. NET PROFIT OF 474 CR V 630 CR LOSS (YOY), UP 39 % (QOQ)
NII UP 26 % AT 2751 CR (YOY), UP 3 % (QOQ)
GROSS NPA AT 3.36 % V 3.7 % (QOQ)
NET NPA AT 1.3 % V 1.53 % (QOQ)
PROVISON DOWN 16 % AT 307 CR (QOQ), DOWN 83 % (YOY)
Better than expected results 👍
CDSL Q1 : CONS. NET PROFIT DOWN 10 % AT 57 CR (YOY), DOWN 25 % (QOQ)
REVENUE UP 20 % AT 140 CR (YOY), UP 3 % (QOQ)
EBITDA UP 3 % AT 75.3 CR (YOY) , DOWN 16 % (QOQ)
MARGINS AT 53.8 % V 62.8 % (YOY) , 66.3 % (QOQ)
Nothing outstanding
ZEN TECH Q1 : CONS. NET PROFIT OF 7.45 CR V 1.14 CR LOSS (YOY), UP 125 % (QOQ)
REVENUE UP 271 % AT 37 CR (YOY), UP 33 % (QOQ)
EBITDA OF 10.78 CR V 1 CR LOSS (YOY), UP 124 % (QOQ)
MARGINS AT 29 % V 17.3 % (QOQ)
Drone business shining 🌟
MCX Q1 : CONS. NET PROFIT UP 4 % AT 41.36 CR (YOY), UP 13 % (QOQ)
REVENUE UP 24 % AT 108.7 CR (YOY), UP 2 % (QOQ)
EBITDA UP 33 % AT 49.2 CR (YOY), DOWN 7 % (QOQ)
MARGINS AT 45.1 % V 42.01 % (YOY), 49.9 % (QOQ)
Nothing much here also...
IDFC FIRST BANK Q1 : ST. NET PROFIT OF 474 CR V 630 CR LOSS (YOY), UP 39 % (QOQ)
NII UP 26 % AT 2751 CR (YOY), UP 3 % (QOQ)
GROSS NPA AT 3.36 % V 3.7 % (QOQ)
NET NPA AT 1.3 % V 1.53 % (QOQ)
PROVISON DOWN 16 % AT 307 CR (QOQ), DOWN 83 % (YOY)
Better than expected results 👍
CDSL Q1 : CONS. NET PROFIT DOWN 10 % AT 57 CR (YOY), DOWN 25 % (QOQ)
REVENUE UP 20 % AT 140 CR (YOY), UP 3 % (QOQ)
EBITDA UP 3 % AT 75.3 CR (YOY) , DOWN 16 % (QOQ)
MARGINS AT 53.8 % V 62.8 % (YOY) , 66.3 % (QOQ)
Nothing outstanding
ZEN TECH Q1 : CONS. NET PROFIT OF 7.45 CR V 1.14 CR LOSS (YOY), UP 125 % (QOQ)
REVENUE UP 271 % AT 37 CR (YOY), UP 33 % (QOQ)
EBITDA OF 10.78 CR V 1 CR LOSS (YOY), UP 124 % (QOQ)
MARGINS AT 29 % V 17.3 % (QOQ)
Drone business shining 🌟
MCX Q1 : CONS. NET PROFIT UP 4 % AT 41.36 CR (YOY), UP 13 % (QOQ)
REVENUE UP 24 % AT 108.7 CR (YOY), UP 2 % (QOQ)
EBITDA UP 33 % AT 49.2 CR (YOY), DOWN 7 % (QOQ)
MARGINS AT 45.1 % V 42.01 % (YOY), 49.9 % (QOQ)
Nothing much here also...
Why So Crypto?
Keep Eyes on Metaverse Coins . Mainly #SAND, #MANA, #GALA close 👀
Don't miss this opportunity!